Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benigno Rodriguez

Showing results (111-120 of 137) with videos related to

Pageof 14
Sort By:
Open Forum Infectious Diseases|April 6, 2019
Effectiveness of Direct-Acting Antiviral Therapy in Patients With Human Immunodeficiency Virus-Hepatitis C Virus Coinfection in Routine Clinical Care: A Multicenter StudyH Nina Kim, Robin M Nance, Jessica S Williams-Nguyen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 21, 2019
Virologic Failure Among People Living With HIV Initiating Dolutegravir-Based Versus Other Recommended Regimens in Real-World Clinical Care SettingsRobin M Nance, Vani Vannappagari, Kimberly Smith, et al.
Progress in Cardiovascular Diseases|February 16, 2020
Physical activity trends and metabolic health outcomes in people living with HIV in the US, 2008-2015Amanda L Willig, Allison R Webel, Andrew O Westfall, et al.
Nature Medicine|November 23, 2006
Microbial translocation is a cause of systemic immune activation in chronic HIV infectionJason M Brenchley, David A Price, Timothy W Schacker, et al.
Blood|February 21, 2013
Impaired T-cell responses to sphingosine-1-phosphate in HIV-1 infected lymph nodesJoseph C Mudd, Patrick Murphy, Maura Manion, et al.
Vaccine|March 19, 2023
Cellular and humoral responses to an HIV DNA prime by electroporation boosted with recombinant vesicular stomatitis virus expressing HIV subtype C Env in a randomized controlled clinical trialGregory J Wilson, Benigno Rodriguez, Shuying Sue Li, et al.
The Journal of Clinical Investigation|October 16, 2018
Cycling CD4+ T cells in HIV-infected immune nonresponders have mitochondrial dysfunctionSouheil-Antoine Younes, Aarthi Talla, Susan Pereira Ribeiro, et al.
AIDS Research and Human Retroviruses|July 10, 2018
Differentiation of Type 1 and Type 2 Myocardial Infarctions Among HIV-Infected Patients Requires Adjudication Due to Overlap in Risk FactorsRobin M Nance, Heidi M Crane, Corey Ritchings, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 2023
Interleukin 6 Blockade With Tocilizumab Diminishes Indices of Inflammation That Are Linked to Mortality in Treated Human Immunodeficiency Virus InfectionNicholas T Funderburg, Carey L Shive, Zhengyi Chen, et al.
Plos Medicine|November 15, 2017
Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trialKenneth H Mayer, Kelly E Seaton, Yunda Huang, et al.
Pageof 14

Showing results (111-120 of 137) with videos related to

Sort By:
Pageof 14
Open Forum Infectious Diseases|April 6, 2019
Effectiveness of Direct-Acting Antiviral Therapy in Patients With Human Immunodeficiency Virus-Hepatitis C Virus Coinfection in Routine Clinical Care: A Multicenter StudyH Nina Kim, Robin M Nance, Jessica S Williams-Nguyen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 21, 2019
Virologic Failure Among People Living With HIV Initiating Dolutegravir-Based Versus Other Recommended Regimens in Real-World Clinical Care SettingsRobin M Nance, Vani Vannappagari, Kimberly Smith, et al.
Progress in Cardiovascular Diseases|February 16, 2020
Physical activity trends and metabolic health outcomes in people living with HIV in the US, 2008-2015Amanda L Willig, Allison R Webel, Andrew O Westfall, et al.
Nature Medicine|November 23, 2006
Microbial translocation is a cause of systemic immune activation in chronic HIV infectionJason M Brenchley, David A Price, Timothy W Schacker, et al.
Blood|February 21, 2013
Impaired T-cell responses to sphingosine-1-phosphate in HIV-1 infected lymph nodesJoseph C Mudd, Patrick Murphy, Maura Manion, et al.
Vaccine|March 19, 2023
Cellular and humoral responses to an HIV DNA prime by electroporation boosted with recombinant vesicular stomatitis virus expressing HIV subtype C Env in a randomized controlled clinical trialGregory J Wilson, Benigno Rodriguez, Shuying Sue Li, et al.
The Journal of Clinical Investigation|October 16, 2018
Cycling CD4+ T cells in HIV-infected immune nonresponders have mitochondrial dysfunctionSouheil-Antoine Younes, Aarthi Talla, Susan Pereira Ribeiro, et al.
AIDS Research and Human Retroviruses|July 10, 2018
Differentiation of Type 1 and Type 2 Myocardial Infarctions Among HIV-Infected Patients Requires Adjudication Due to Overlap in Risk FactorsRobin M Nance, Heidi M Crane, Corey Ritchings, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 2023
Interleukin 6 Blockade With Tocilizumab Diminishes Indices of Inflammation That Are Linked to Mortality in Treated Human Immunodeficiency Virus InfectionNicholas T Funderburg, Carey L Shive, Zhengyi Chen, et al.
Plos Medicine|November 15, 2017
Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trialKenneth H Mayer, Kelly E Seaton, Yunda Huang, et al.
Pageof 14